Skip to main content
Top
Published in: Journal of Neural Transmission 2/2018

Open Access 01-02-2018 | Neurology and Preclinical Neurological Studies - Original Article

Risky decision-making and affective features of impulse control disorders in Parkinson’s disease

Authors: Alice Martini, Simon J. Ellis, James A. Grange, Stefano Tamburin, Denise Dal Lago, Greta Vianello, Nicola M. J. Edelstyn

Published in: Journal of Neural Transmission | Issue 2/2018

Login to get access

Abstract

Impulse control disorders (ICDs) in Parkinson’s disease (PD) are considered dopaminergic treatment side effects. Cognitive and affective factors may increase the risk of ICD in PD. The aim is to investigate risky decision-making and associated cognitive processes in PD patients with ICDs within a four-stage conceptual framework. Relationship between ICDs and affective factors was explored. Thirteen PD patients with ICD (ICD+), 12 PD patients without ICD (ICD−), and 17 healthy controls were recruited. Overall risky decision-making and negative feedback effect were examined with the Balloon Analogue Risk Task (BART). A cognitive battery dissected decision-making processes according to the four-stage conceptual framework. Affective and motivational factors were measured. ANOVA showed no effect of group on overall risky decision-making. However, there was a group × feedback interaction [F (2, 39) = 3.31, p = 0.047]. ICD+, unlike ICD− and healthy controls, failed to reduce risky behaviour following negative feedback. A main effect of group was found for anxiety and depression [F(2, 38) = 8.31, p = 0.001], with higher symptoms in ICD+ vs. healthy controls. Groups did not differ in cognitive outcomes or affective and motivational metrics. ICD+ may show relatively preserved cognitive function, but reduced sensitivity to negative feedback during risky decision-making and higher symptoms of depression and anxiety.
Appendix
Available only for authorised users
Literature
go back to reference American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5). American Psychiatric Association, New YorkCrossRef American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5). American Psychiatric Association, New YorkCrossRef
go back to reference Antonini A, Siri C, Santangelo G et al (2011) Impulsivity and compulsivity in drug-naïve patients with Parkinson’s disease. Mov Disord 26(3):464–468CrossRefPubMed Antonini A, Siri C, Santangelo G et al (2011) Impulsivity and compulsivity in drug-naïve patients with Parkinson’s disease. Mov Disord 26(3):464–468CrossRefPubMed
go back to reference Burgess PW, Shallice T (1997) The Hayling and Brixton tests. Thames Valley Test Company Limited, Bury St Edmunds Burgess PW, Shallice T (1997) The Hayling and Brixton tests. Thames Valley Test Company Limited, Bury St Edmunds
go back to reference Callesen MB, Weintraub D, Damholdt MF, Møller A (2014) Impulsive and compulsive behaviors among Danish patients with Parkinson’s disease: prevalence, depression, and personality. Parkinsonism Relat Disord 20(1):22–26CrossRefPubMed Callesen MB, Weintraub D, Damholdt MF, Møller A (2014) Impulsive and compulsive behaviors among Danish patients with Parkinson’s disease: prevalence, depression, and personality. Parkinsonism Relat Disord 20(1):22–26CrossRefPubMed
go back to reference Claassen DO, van den Wildenberg WPM, Ridderinkhof KR, Jessup CK, Harrison MB, Wooten GF, Wylie SA (2011) The risky business of dopamine agonists in Parkinson disease and impulse control disorders. Behav Neurosci 125(4):492–500CrossRefPubMedPubMedCentral Claassen DO, van den Wildenberg WPM, Ridderinkhof KR, Jessup CK, Harrison MB, Wooten GF, Wylie SA (2011) The risky business of dopamine agonists in Parkinson disease and impulse control disorders. Behav Neurosci 125(4):492–500CrossRefPubMedPubMedCentral
go back to reference Claassen DO, van den Wildenberg WPM, Harrison MB, van Wouwe NC, Kanoff K, Neimat JS, Wylie SA (2015) Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors. Pharmacol Biochem Behav 129:19–25CrossRefPubMed Claassen DO, van den Wildenberg WPM, Harrison MB, van Wouwe NC, Kanoff K, Neimat JS, Wylie SA (2015) Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors. Pharmacol Biochem Behav 129:19–25CrossRefPubMed
go back to reference Cockburn J, Frank MJ (2011) Reinforcement learning, conflict monitoring, and cognitive control: an integrative model of cingulate-striatal interactions and the ERN. Neural Basis Motiv Cogn Control 9:311–331 Cockburn J, Frank MJ (2011) Reinforcement learning, conflict monitoring, and cognitive control: an integrative model of cingulate-striatal interactions and the ERN. Neural Basis Motiv Cogn Control 9:311–331
go back to reference Cools R, Robbins TW (2004) Chemistry of the adaptive mind. Philos Trans A Math Phys Eng Sci 362(1825):2871–2888CrossRefPubMed Cools R, Robbins TW (2004) Chemistry of the adaptive mind. Philos Trans A Math Phys Eng Sci 362(1825):2871–2888CrossRefPubMed
go back to reference Cools R, Barker RA, Sahakian BJ, Robbins TW (2001) Enhanced or impaired cognitive function in Parkinson’s disease as a function of dopaminergic medication and task demands. Cereb Cortex 11(12):1136–1143CrossRefPubMed Cools R, Barker RA, Sahakian BJ, Robbins TW (2001) Enhanced or impaired cognitive function in Parkinson’s disease as a function of dopaminergic medication and task demands. Cereb Cortex 11(12):1136–1143CrossRefPubMed
go back to reference Di Rosa E, Schiff S, Cagnolati F, Mapelli D (2015) Motivation-cognition interaction: how feedback processing changes in healthy ageing and in Parkinson’s disease. Aging Clin Exp Res 27(6):911–920CrossRefPubMed Di Rosa E, Schiff S, Cagnolati F, Mapelli D (2015) Motivation-cognition interaction: how feedback processing changes in healthy ageing and in Parkinson’s disease. Aging Clin Exp Res 27(6):911–920CrossRefPubMed
go back to reference Djamshidian A, Jha A, O’Sullivan SS et al (2010) Risk and learning in impulsive and nonimpulsive patients with Parkinson’s disease. Mov Disord 25(13):2203–2210CrossRefPubMedPubMedCentral Djamshidian A, Jha A, O’Sullivan SS et al (2010) Risk and learning in impulsive and nonimpulsive patients with Parkinson’s disease. Mov Disord 25(13):2203–2210CrossRefPubMedPubMedCentral
go back to reference Djamshidian A, O’Sullivan SS, Lees A, Averbeck BB (2011) Stroop test performance in impulsive and non impulsive patients with Parkinson’s disease. Parkinsonism Relat Disord 17(3):212–214CrossRefPubMedPubMedCentral Djamshidian A, O’Sullivan SS, Lees A, Averbeck BB (2011) Stroop test performance in impulsive and non impulsive patients with Parkinson’s disease. Parkinsonism Relat Disord 17(3):212–214CrossRefPubMedPubMedCentral
go back to reference Djamshidian A, O’Sullivan SS, Sanotsky Y et al (2012) Decision making, impulsivity, and addictions: do Parkinson’s disease patients jump to conclusions? Mov Disord 27(9):1137–1145CrossRefPubMedPubMedCentral Djamshidian A, O’Sullivan SS, Sanotsky Y et al (2012) Decision making, impulsivity, and addictions: do Parkinson’s disease patients jump to conclusions? Mov Disord 27(9):1137–1145CrossRefPubMedPubMedCentral
go back to reference Djamshidian A, O’Sullivan SS, Lawrence AD et al (2014) Perceptual decision-making in patients with Parkinson’s disease. J Psychopharmacol 28(12):1149–1154CrossRefPubMed Djamshidian A, O’Sullivan SS, Lawrence AD et al (2014) Perceptual decision-making in patients with Parkinson’s disease. J Psychopharmacol 28(12):1149–1154CrossRefPubMed
go back to reference Evans AH, Katzenschlager R, Paviour D, O’Sullivan JD, Appel S, Lawrence AD, Lees AJ (2004) Punding in Parkinson’s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19(4):397–405CrossRefPubMed Evans AH, Katzenschlager R, Paviour D, O’Sullivan JD, Appel S, Lawrence AD, Lees AJ (2004) Punding in Parkinson’s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19(4):397–405CrossRefPubMed
go back to reference Evans AH, Strafella AP, Weintraub D, Stacy M (2009) Impulsive and compulsive behaviors in Parkinson’s disease. Mov Disord 24(11):1561–1570CrossRefPubMed Evans AH, Strafella AP, Weintraub D, Stacy M (2009) Impulsive and compulsive behaviors in Parkinson’s disease. Mov Disord 24(11):1561–1570CrossRefPubMed
go back to reference Frank MJ, O’Reilly RC, Seeberger LC (2004) By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 306(5703):1940–1943CrossRefPubMed Frank MJ, O’Reilly RC, Seeberger LC (2004) By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science 306(5703):1940–1943CrossRefPubMed
go back to reference Garcia-Ruiz PJ, Castrillo JCM, Alonso-Canovas A et al (2014) Impulse control disorder in patients with Parkinson’s disease under dopamine agonist therapy: a multicentre study. J Neurol Neurosurg Psychiatry 85(8):840–844CrossRefPubMed Garcia-Ruiz PJ, Castrillo JCM, Alonso-Canovas A et al (2014) Impulse control disorder in patients with Parkinson’s disease under dopamine agonist therapy: a multicentre study. J Neurol Neurosurg Psychiatry 85(8):840–844CrossRefPubMed
go back to reference Giovannoni G, Sullivan JDO, Turner K, Manson AJ, Lees AJL (2000) Hedonistic homeostatic dysregulation in patients with Parkinson’ s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68(4):423–428CrossRefPubMedPubMedCentral Giovannoni G, Sullivan JDO, Turner K, Manson AJ, Lees AJL (2000) Hedonistic homeostatic dysregulation in patients with Parkinson’ s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68(4):423–428CrossRefPubMedPubMedCentral
go back to reference Gotham AM, Brown RG, Marsden CD (1988) ’Frontal’ cognitive function in patients with Parkinson’s disease ‘on’ and ‘off’ levodopa. Brain 111:299–321CrossRefPubMed Gotham AM, Brown RG, Marsden CD (1988) ’Frontal’ cognitive function in patients with Parkinson’s disease ‘on’ and ‘off’ levodopa. Brain 111:299–321CrossRefPubMed
go back to reference Holroyd CB, Coles MGH (2002) The neural basis of human error processing: reinforcement learning, dopamine, and the error-related negativity. Psychol Rev 109(4):679–709CrossRefPubMed Holroyd CB, Coles MGH (2002) The neural basis of human error processing: reinforcement learning, dopamine, and the error-related negativity. Psychol Rev 109(4):679–709CrossRefPubMed
go back to reference Hopko DR, Lejuez CW, Daughters SB, Aklin WM, Osborne A, Simmons BL, Strong DR (2006) Construct validity of the balloon analogue risk task (BART): relationship with MDMA use by inner-city drug users in residential treatment. J Psychopathol Behav Assess 28(2):95–101CrossRef Hopko DR, Lejuez CW, Daughters SB, Aklin WM, Osborne A, Simmons BL, Strong DR (2006) Construct validity of the balloon analogue risk task (BART): relationship with MDMA use by inner-city drug users in residential treatment. J Psychopathol Behav Assess 28(2):95–101CrossRef
go back to reference Housden CR, O’Sullivan SS, Joyce EM, Lees AJ, Roiser JP (2010) Intact reward learning but elevated delay discounting in Parkinson’s disease patients with impulsive-compulsive spectrum behaviors. Neuropsychopharmacology 35(11):2155–2164CrossRefPubMedPubMedCentral Housden CR, O’Sullivan SS, Joyce EM, Lees AJ, Roiser JP (2010) Intact reward learning but elevated delay discounting in Parkinson’s disease patients with impulsive-compulsive spectrum behaviors. Neuropsychopharmacology 35(11):2155–2164CrossRefPubMedPubMedCentral
go back to reference Ishihara L, Brayne C (2006) A systematic review of depression and mental illness preceding Parkinson’s disease. Acta Neurol Scand 113(4):211–220CrossRefPubMed Ishihara L, Brayne C (2006) A systematic review of depression and mental illness preceding Parkinson’s disease. Acta Neurol Scand 113(4):211–220CrossRefPubMed
go back to reference Jocham G, Ullsperger M (2009) Neuropharmacology of performance monitoring. Neurosci Biobehav Rev 33(1):48–60CrossRefPubMed Jocham G, Ullsperger M (2009) Neuropharmacology of performance monitoring. Neurosci Biobehav Rev 33(1):48–60CrossRefPubMed
go back to reference Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540–545CrossRefPubMed Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540–545CrossRefPubMed
go back to reference Joutsa J, Martikainen K, Vahlberg T, Voon V, Kaasinen V (2012) Impulse control disorders and depression in Finnish patients with Parkinson’s disease. Parkinsonism Relat Disord 18(2):155–160CrossRefPubMed Joutsa J, Martikainen K, Vahlberg T, Voon V, Kaasinen V (2012) Impulse control disorders and depression in Finnish patients with Parkinson’s disease. Parkinsonism Relat Disord 18(2):155–160CrossRefPubMed
go back to reference Kirby KN, Petry NM, Bickel WK (1999) Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen 128(1):78–87CrossRefPubMed Kirby KN, Petry NM, Bickel WK (1999) Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen 128(1):78–87CrossRefPubMed
go back to reference Lejuez CW, Read JP, Kahler CW et al (2002) Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART). J Exp Psychol Appl 8(2):75–84CrossRefPubMed Lejuez CW, Read JP, Kahler CW et al (2002) Evaluation of a behavioral measure of risk taking: the Balloon Analogue Risk Task (BART). J Exp Psychol Appl 8(2):75–84CrossRefPubMed
go back to reference Lejuez CW, Aklin WM, Jones HA, Richards JB, Strong DR, Kahler CW, Read JP (2003a) The Balloon Analogue Risk Task (BART) differentiates smokers and nonsmokers. Exp Clin Psychopharmacol 11(1):26–33CrossRefPubMed Lejuez CW, Aklin WM, Jones HA, Richards JB, Strong DR, Kahler CW, Read JP (2003a) The Balloon Analogue Risk Task (BART) differentiates smokers and nonsmokers. Exp Clin Psychopharmacol 11(1):26–33CrossRefPubMed
go back to reference Lejuez CW, Aklin WM, Zvolensky MJ, Pedulla CM (2003b) Evaluation of the Balloon Analogue Risk Task (BART) as a predictor of adolescent real-world risk-taking behaviours. J Adolesc 26(4):475–479CrossRefPubMed Lejuez CW, Aklin WM, Zvolensky MJ, Pedulla CM (2003b) Evaluation of the Balloon Analogue Risk Task (BART) as a predictor of adolescent real-world risk-taking behaviours. J Adolesc 26(4):475–479CrossRefPubMed
go back to reference Leplow B, Sepke M, Schönfeld R, Pohl J, Oelsner H, Latzko L, Ebersbach G (2017) Impaired learning of punishments in Parkinson’s disease with and without impulse control disorder. J Neural Transm 124(2):217–225CrossRefPubMed Leplow B, Sepke M, Schönfeld R, Pohl J, Oelsner H, Latzko L, Ebersbach G (2017) Impaired learning of punishments in Parkinson’s disease with and without impulse control disorder. J Neural Transm 124(2):217–225CrossRefPubMed
go back to reference Leroi I, Ahearn DJ, Andrews M, McDonald KR, Byrne EJ, Burns A (2011) Behavioural disorders, disability and quality of life in Parkinson’s disease. Age Ageing 40:614–621CrossRefPubMed Leroi I, Ahearn DJ, Andrews M, McDonald KR, Byrne EJ, Burns A (2011) Behavioural disorders, disability and quality of life in Parkinson’s disease. Age Ageing 40:614–621CrossRefPubMed
go back to reference Leroi I, Andrews M, McDonald K, Harbishettar V, Elliott R, Byrne EJ, Burns A (2012) Apathy and impulse control disorders in Parkinson’s disease: a direct comparison. Parkinsonism Relat Disord 18(2):198–203CrossRefPubMed Leroi I, Andrews M, McDonald K, Harbishettar V, Elliott R, Byrne EJ, Burns A (2012) Apathy and impulse control disorders in Parkinson’s disease: a direct comparison. Parkinsonism Relat Disord 18(2):198–203CrossRefPubMed
go back to reference McElroy SL, Keck PE, Pope HG, Smith JM, Strakowski SM (1994) Compulsive buying: a report of 20 cases. J Clin Psychiatry 55(6):242–248PubMed McElroy SL, Keck PE, Pope HG, Smith JM, Strakowski SM (1994) Compulsive buying: a report of 20 cases. J Clin Psychiatry 55(6):242–248PubMed
go back to reference Myerson J, Baumann AA, Green L (2014) Discounting of delayed rewards: (A)theoretical interpretation of the Kirby questionnaire. Behav Process 107:99–105CrossRef Myerson J, Baumann AA, Green L (2014) Discounting of delayed rewards: (A)theoretical interpretation of the Kirby questionnaire. Behav Process 107:99–105CrossRef
go back to reference O’Sullivan S, Loane CM, Lawrence AD, Evans AH, Piccini P, Lees AJ (2011) Sleep disturbance and impulsive-compulsive behaviours in Parkinson’ s disease. J Neurol Neurosurg Psychiatry 82(6):620–622CrossRefPubMed O’Sullivan S, Loane CM, Lawrence AD, Evans AH, Piccini P, Lees AJ (2011) Sleep disturbance and impulsive-compulsive behaviours in Parkinson’ s disease. J Neurol Neurosurg Psychiatry 82(6):620–622CrossRefPubMed
go back to reference Patton JH, Stanford MS, Barratt ES (1995) Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51(6):768–774CrossRefPubMed Patton JH, Stanford MS, Barratt ES (1995) Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51(6):768–774CrossRefPubMed
go back to reference Phu AL, Xu Z, Brakoulias V et al (2014) Effect of impulse control disorders on disability and quality of life in Parkinson’s disease patients. J Clin Neurosci 21(1):63–66CrossRefPubMed Phu AL, Xu Z, Brakoulias V et al (2014) Effect of impulse control disorders on disability and quality of life in Parkinson’s disease patients. J Clin Neurosci 21(1):63–66CrossRefPubMed
go back to reference Pineau F, Roze E, Lacomblez L, Bonnet AM, Vidailhet M, Czernecki V, Corvol JC (2016) Executive functioning and risk-taking behavior in Parkinson’s disease patients with impulse control disorders. J Neural Transm 123(6):573–581CrossRefPubMed Pineau F, Roze E, Lacomblez L, Bonnet AM, Vidailhet M, Czernecki V, Corvol JC (2016) Executive functioning and risk-taking behavior in Parkinson’s disease patients with impulse control disorders. J Neural Transm 123(6):573–581CrossRefPubMed
go back to reference Piray P, Zeighami Y, Bahrami F, Eissa AM, Hewedi DH, Moustafa AA (2014) Impulse control disorders in Parkinson’s disease are associated with dysfunction in stimulus valuation but not action valuation. J Neurosci 34(23):7814–7824CrossRefPubMed Piray P, Zeighami Y, Bahrami F, Eissa AM, Hewedi DH, Moustafa AA (2014) Impulse control disorders in Parkinson’s disease are associated with dysfunction in stimulus valuation but not action valuation. J Neurosci 34(23):7814–7824CrossRefPubMed
go back to reference Pontieri FE, Assogna F, Pellicano C et al (2015) Sociodemographic, neuropsychiatric and cognitive characteristics of pathological gambling and impulse control disorders NOS in Parkinson’s disease. Eur Neuropsychopharmacol 25(1):69–76CrossRefPubMed Pontieri FE, Assogna F, Pellicano C et al (2015) Sociodemographic, neuropsychiatric and cognitive characteristics of pathological gambling and impulse control disorders NOS in Parkinson’s disease. Eur Neuropsychopharmacol 25(1):69–76CrossRefPubMed
go back to reference Pontone G, Williams JR, Bassett SS, Marsh L (2006) Clinical features associated with impulse control disorders in Parkinson disease. Neurology 67(7):1258–1261CrossRefPubMed Pontone G, Williams JR, Bassett SS, Marsh L (2006) Clinical features associated with impulse control disorders in Parkinson disease. Neurology 67(7):1258–1261CrossRefPubMed
go back to reference Prediger RDS, Matheus FC, Schwarzbold ML, Lima MM, Vital MA (2012) Anxiety in Parkinson’s disease: a critical review of experimental and clinical studies. Neuropharmacology 62(1):115–124CrossRefPubMed Prediger RDS, Matheus FC, Schwarzbold ML, Lima MM, Vital MA (2012) Anxiety in Parkinson’s disease: a critical review of experimental and clinical studies. Neuropharmacology 62(1):115–124CrossRefPubMed
go back to reference Rao H, Mamikonyan E, Detre JA, Siderowf AD, Stern MB, Potenza MN, Weintraub D (2010) Decreased ventral striatal activity with impulse control disorders in Parkinson’s disease. Mov Disord 25(11):1660–1669CrossRefPubMedPubMedCentral Rao H, Mamikonyan E, Detre JA, Siderowf AD, Stern MB, Potenza MN, Weintraub D (2010) Decreased ventral striatal activity with impulse control disorders in Parkinson’s disease. Mov Disord 25(11):1660–1669CrossRefPubMedPubMedCentral
go back to reference Reitan R (1958) Validity of the Trail Making Test as an indicator of organic brain damage. Percep Mot Skills 8:271–276CrossRef Reitan R (1958) Validity of the Trail Making Test as an indicator of organic brain damage. Percep Mot Skills 8:271–276CrossRef
go back to reference Roth M, Tym E, Mountjoy CQ (1986) CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149(6):698–709CrossRefPubMed Roth M, Tym E, Mountjoy CQ (1986) CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149(6):698–709CrossRefPubMed
go back to reference Rowe JB, Hughes L, Ghosh BCP et al (2008) Parkinson’s disease and dopaminergic therapy-differential effects on movement, reward and cognition. Brain 131(8):2094–2105CrossRefPubMedPubMedCentral Rowe JB, Hughes L, Ghosh BCP et al (2008) Parkinson’s disease and dopaminergic therapy-differential effects on movement, reward and cognition. Brain 131(8):2094–2105CrossRefPubMedPubMedCentral
go back to reference Santangelo G, Raimo S, Barone P (2017) The relationship between impulse control disorders and cognitive dysfunctions in Parkinson’s disease: a meta-analysis. Neurosci Biobehav Rev 77:129–147CrossRefPubMed Santangelo G, Raimo S, Barone P (2017) The relationship between impulse control disorders and cognitive dysfunctions in Parkinson’s disease: a meta-analysis. Neurosci Biobehav Rev 77:129–147CrossRefPubMed
go back to reference Scullin MK, Sollinger AB, Land J et al (2013) Sleep and impulsivity in Parkinson’s disease. Parkinsonism Relat Disord 19(11):991–994CrossRefPubMed Scullin MK, Sollinger AB, Land J et al (2013) Sleep and impulsivity in Parkinson’s disease. Parkinsonism Relat Disord 19(11):991–994CrossRefPubMed
go back to reference Simioni AC, Dagher A, Fellows LK (2012) Dissecting the effects of disease and treatment on impulsivity in Parkinson’s disease. J Int Neuropsychol Soc 18(6):942–951CrossRefPubMed Simioni AC, Dagher A, Fellows LK (2012) Dissecting the effects of disease and treatment on impulsivity in Parkinson’s disease. J Int Neuropsychol Soc 18(6):942–951CrossRefPubMed
go back to reference Sinha N, Manohar S, Husain M (2013) Impulsivity and apathy in Parkinson’s disease. J Neuropsychol 7(2):255–283CrossRefPubMed Sinha N, Manohar S, Husain M (2013) Impulsivity and apathy in Parkinson’s disease. J Neuropsychol 7(2):255–283CrossRefPubMed
go back to reference Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG (1992) Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 4(2):134–139CrossRefPubMed Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG (1992) Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 4(2):134–139CrossRefPubMed
go back to reference Tolosa E, Gaig C, Santamaría J, Compta Y (2009) Diagnosis and the premotor phase of Parkinson disease. Neurology 72(7 Suppl 2):S12–S20CrossRefPubMed Tolosa E, Gaig C, Santamaría J, Compta Y (2009) Diagnosis and the premotor phase of Parkinson disease. Neurology 72(7 Suppl 2):S12–S20CrossRefPubMed
go back to reference Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2685CrossRefPubMed Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2685CrossRefPubMed
go back to reference Volpato C, Schiff S, Facchini S et al (2016) Dopaminergic medication modulates learning from feedback and error-related negativity in Parkinson’s disease: a pilot study. Front Behav Neurosci 10:1–8CrossRef Volpato C, Schiff S, Facchini S et al (2016) Dopaminergic medication modulates learning from feedback and error-related negativity in Parkinson’s disease: a pilot study. Front Behav Neurosci 10:1–8CrossRef
go back to reference Voon V, Hassan K, Zurowski M et al (2006) Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 67(7):1254–1257CrossRefPubMed Voon V, Hassan K, Zurowski M et al (2006) Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 67(7):1254–1257CrossRefPubMed
go back to reference Voon V, Potenza MN, Thomsen T (2007) Medication-related impulse control and repetitive behaviors in Parkinson disease. Curr Opin Neurol 20(4):484–492CrossRefPubMed Voon V, Potenza MN, Thomsen T (2007) Medication-related impulse control and repetitive behaviors in Parkinson disease. Curr Opin Neurol 20(4):484–492CrossRefPubMed
go back to reference Voon V, Pessiglione M, Brezing C, Gallea C, Fernandez HH, Dolan RJ, Hallett M (2010a) Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 65(1):135–142CrossRefPubMedPubMedCentral Voon V, Pessiglione M, Brezing C, Gallea C, Fernandez HH, Dolan RJ, Hallett M (2010a) Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 65(1):135–142CrossRefPubMedPubMedCentral
go back to reference Voon V, Reynolds B, Brezing C et al (2010b) Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology 207(4):645–659CrossRefPubMed Voon V, Reynolds B, Brezing C et al (2010b) Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology 207(4):645–659CrossRefPubMed
go back to reference Voon V, Sohr M, Lang AE et al (2011b) Impulse control disorders in Parkinson disease: a multicenter case-control study. Ann Neurol 69(6):986–996CrossRefPubMed Voon V, Sohr M, Lang AE et al (2011b) Impulse control disorders in Parkinson disease: a multicenter case-control study. Ann Neurol 69(6):986–996CrossRefPubMed
go back to reference Vriend C, Nordbeck AH, Booij J et al (2014a) Reduced dopamine transporter binding predates impulse control disorders in Parkinson’s disease. Mov Disord 29(7):904–911CrossRefPubMed Vriend C, Nordbeck AH, Booij J et al (2014a) Reduced dopamine transporter binding predates impulse control disorders in Parkinson’s disease. Mov Disord 29(7):904–911CrossRefPubMed
go back to reference Vriend C, Pattij T, van der Werf YD et al (2014b) Depression and impulse control disorders in Parkinson’s disease: two sides of the same coin? Neurosci Biobehav Rev 38:60–71CrossRefPubMed Vriend C, Pattij T, van der Werf YD et al (2014b) Depression and impulse control disorders in Parkinson’s disease: two sides of the same coin? Neurosci Biobehav Rev 38:60–71CrossRefPubMed
go back to reference Wechsler D (2009a) Test of premorbid functioning. The Psychological Corporation, San Antonio Wechsler D (2009a) Test of premorbid functioning. The Psychological Corporation, San Antonio
go back to reference Wechsler D (2009b) Wechsler Memory Scale-Fourth Edition (WMS-IV). Pearson Assessment, San Antonio Wechsler D (2009b) Wechsler Memory Scale-Fourth Edition (WMS-IV). Pearson Assessment, San Antonio
go back to reference Weintraub D, Koester J, Potenza M et al (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67(5):589–595CrossRefPubMed Weintraub D, Koester J, Potenza M et al (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67(5):589–595CrossRefPubMed
go back to reference Weintraub D, David AS, Evans AH, Grant JE, Stacy M (2015) Clinical spectrum of impulse control disorders in Parkinson’s disease. Mov Disord 30(2):121–127CrossRefPubMed Weintraub D, David AS, Evans AH, Grant JE, Stacy M (2015) Clinical spectrum of impulse control disorders in Parkinson’s disease. Mov Disord 30(2):121–127CrossRefPubMed
go back to reference Wu K, Politis M, O’Sullivan SS et al (2015) Single versus multiple impulse control disorders in Parkinson’s disease: an (11)C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release. J Neurol 262(6):1504–1514CrossRefPubMed Wu K, Politis M, O’Sullivan SS et al (2015) Single versus multiple impulse control disorders in Parkinson’s disease: an (11)C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release. J Neurol 262(6):1504–1514CrossRefPubMed
go back to reference Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed
go back to reference Zimmermann P, Fimm B (1995) Test for attentional performance (TAP). PsyTest, Herzogenrath, pp 76–77 Zimmermann P, Fimm B (1995) Test for attentional performance (TAP). PsyTest, Herzogenrath, pp 76–77
Metadata
Title
Risky decision-making and affective features of impulse control disorders in Parkinson’s disease
Authors
Alice Martini
Simon J. Ellis
James A. Grange
Stefano Tamburin
Denise Dal Lago
Greta Vianello
Nicola M. J. Edelstyn
Publication date
01-02-2018
Publisher
Springer Vienna
Published in
Journal of Neural Transmission / Issue 2/2018
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-017-1807-7

Other articles of this Issue 2/2018

Journal of Neural Transmission 2/2018 Go to the issue

Psychiatry and Preclinical Psychiatric Studies - Original Article

Fluid biomarker agreement and interrelation in dementia due to Alzheimer’s disease